ENTITY

Aldeyra Therapeutics (ALDX US)

Analysis

Health Care • United States

Aldeyra Therapeutics, Inc. provides medical services. The Company deals in treatment and research for dry eye disease, allergic conjunctivitis, and other forms of ocular inflammation. Aldeyra Therapeutics serves patients in the United States.

Refresh

Company Event • 08 Mar 2025 05:00 • Upcoming

Add To Calendar

Q4 2024

Company Event • 08 Nov 2024 04:00 • Upcoming

Add To Calendar

Q3 2024

Company Event • 08 Aug 2024 21:00 • Latest

Study Update

Company Event • 01 Aug 2024 06:00 • Upcoming

Add To Calendar

Q2 2024

Company Event • 20 Jun 2024 20:00

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Q4 2024

Q3 2024

Study Update

Q2 2024

Status Update